000			01613 a2200457 4500
005			20250511201401.0
264		0	_c19910305
008			199103s 0 0 eng d
022			_a0041-1345
040			_aNLM _beng _cNLM
100	1		_aMorris, R E
245	0	0	_aUse of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. _h[electronic resource]
260			_bTransplantation proceedings _cFeb 1991
300			_a521-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aCyclosporins _xtherapeutic use
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Synergism
650	0	4	_aGraft Survival
650	0	4	_aGraft vs Host Reaction
650	0	4	_aHeart Transplantation _ximmunology
650	0	4	_aHost vs Graft Reaction
650	0	4	_aImmunosuppression Therapy
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aLymph Nodes _ximmunology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aPolyenes _xadministration & dosage
650	0	4	_aSirolimus
650	0	4	_aTacrolimus
650	0	4	_aTransplantation, Homologous
700	1		_aMeiser, B M
700	1		_aWu, J
700	1		_aShorthouse, R
700	1		_aWang, J
773	0		_tTransplantation proceedings _gvol. 23 _gno. 1 Pt 1 _gp. 521-4
999			_c1710099 _d1710099